Sema4 Holdings Corp
NASDAQ:SMFR
Intrinsic Value
Sema4 Holdings Corp.is a patient centered health intelligence company. [ Read More ]
The intrinsic value of one SMFR stock under the Base Case scenario is 0.3624 USD. Compared to the current market price of 0.3431 USD, Sema4 Holdings Corp is Undervalued by 5%.
Valuation Backtest
Sema4 Holdings Corp
Run backtest to discover the historical profit from buying and selling SMFR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Sema4 Holdings Corp's business.
What risks and challenges
does Sema4 Holdings Corp face in the near future?
Summarize the latest earnings report
of Sema4 Holdings Corp.
Provide P/E
for Sema4 Holdings Corp and its competitors.
Balance Sheet Decomposition
Sema4 Holdings Corp
Current Assets | 212.6m |
Cash & Short-Term Investments | 123.9m |
Receivables | 43.3m |
Other Current Assets | 45.3m |
Non-Current Assets | 278.3m |
PP&E | 84.3m |
Intangibles | 186.7m |
Other Non-Current Assets | 7.4m |
Current Liabilities | 144.3m |
Accounts Payable | 47.6m |
Accrued Liabilities | 53.7m |
Other Current Liabilities | 43m |
Non-Current Liabilities | 92.9m |
Long-Term Debt | 21.8m |
Other Non-Current Liabilities | 71.1m |
Earnings Waterfall
Sema4 Holdings Corp
Revenue
|
234.7m
USD
|
Cost of Revenue
|
-261.4m
USD
|
Gross Profit
|
-26.8m
USD
|
Operating Expenses
|
-640.9m
USD
|
Operating Income
|
-667.7m
USD
|
Other Expenses
|
118.7m
USD
|
Net Income
|
-549m
USD
|
Free Cash Flow Analysis
Sema4 Holdings Corp
What is Free Cash Flow?
SMFR Profitability Score
Profitability Due Diligence
Sema4 Holdings Corp's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
Score
Sema4 Holdings Corp's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
SMFR Solvency Score
Solvency Due Diligence
Sema4 Holdings Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
Sema4 Holdings Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SMFR Price Targets Summary
Sema4 Holdings Corp
Ownership
SMFR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
SMFR Price
Sema4 Holdings Corp
Average Annual Return | -23.95% |
Standard Deviation of Annual Returns | 47.57% |
Max Drawdown | -99% |
Market Capitalization | 132.7m USD |
Shares Outstanding | 386 795 008 |
Percentage of Shares Shorted | 1.85% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sema4 Holdings Corp.is a patient centered health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,200 full-time employees. The company went IPO on 2020-09-04. The firm applies artificial intelligence and machine learning to clinical and genomic data to build models of human health and define individualized health trajectories. The Company’s health intelligence platform, Centrellis enables users to generate a complete understanding of disease and wellness and to provide science-driven solutions to pressing medical needs. Its Expanded Carrier Screen (ECS) is a carrier screen for inherited conditions. Its Noninvasive Prenatal Testing Solutions is a test that screens for autosomal and sex chromosome aneuploidies. Its Natalis Newborn Screening Solutions is a test of its screening portfolio allowing for detection of heritable conditions from pre-conception, pregnancy and childhood. The firm also includes Signal Precision Oncology Solutions.
Contact
IPO
Employees
Officers
The intrinsic value of one SMFR stock under the Base Case scenario is 0.3624 USD.
Compared to the current market price of 0.3431 USD, Sema4 Holdings Corp is Undervalued by 5%.